Analyst Ranking
Top 29%
#1504 out of 5256 analysts
Average Return
+11.29%
Win Rate
47%9 out of 19
Risk vs Reward
Poor
Good

Carl Byrnes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Brainsway LtdBWAY
+144.43%$6.42$15.68
2025-08-13 -
2026-04-20
Buy
Brainsway LtdBWAY
+133.50%$1.00$2.34
2022-11-16 -
2023-11-16
Buy
Gw Pharmaceuticals PLCGWPH
+123.25%$97.65$218.00
2020-04-07 -
2021-04-08
Buy
Brainsway LtdBWAY
+98.73%$7.89$15.68
2025-11-11 -
2026-04-20
Buy
Brainsway LtdBWAY
+73.61%$3.41$5.92
2024-08-06 -
2025-08-06
Buy

Carl Byrnes Analyst Color

Get additional color on Carl Byrnes's coverage of popular stocks

Carl Byrnes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Avita Medical IncRCEL
1Buy$10.00+100.00%Initiates Coverage On
2 months ago
Brainsway LtdBWAY
5Buy$11.50-26.66%Maintains
5 months ago
SNWV
1Buy$55.00N/AInitiates Coverage On
8 months ago
Biolife Solutions IncBLFS
2Buy$31.00N/AMaintains
a year ago
Trisalus Life Sciences IncTLSI
1Buy$12.50N/AInitiates Coverage On
a year ago
Oncternal Therapeutics IncONCT
1Hold$2.00N/ADowngrades
2 years ago
Spectral Ai IncMDAI
1Buy$6.00N/AInitiates Coverage On
2 years ago
Amarin Corp PLCAMRN
1Hold$25.00N/AMaintains
3 years ago
Cardio Diagnostics Holdings IncCDIO
1Buy$240.00N/AInitiates Coverage On
3 years ago
Polarityte IncPTEIQ
1Buy$1.00N/AMaintains
3 years ago
Vtv Therapeutics IncVTVT
2Buy$80.00N/AMaintains
4 years ago
Nabriva Therapeutics PLCNBRVF
1Buy$50.00N/AMaintains
4 years ago
Flexion Therapeutics IncFLXN1
1HoldN/AN/ADowngrades
4 years ago
Adamas Pharmaceuticals IncADMS
1Hold$8.50N/ADowngrades
4 years ago
Skylight Health Group IncSLHGF
1Buy$9.00N/AInitiates Coverage On
5 years ago
Mimedx Group IncMDXG
1Buy$23.00N/AInitiates Coverage On
5 years ago
Esperion Therapeutics IncESPR
4Hold$24.00N/AMaintains
5 years ago
Gw Pharmaceuticals PLCGWPH
1Buy$128.00N/AInitiates Coverage On
6 years ago
Aytu Biopharma IncAYTU
1Buy$2,000.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.